1-3 of 3
Arne Strauß
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Sunitinib for Metastatic Renal Cell Carcinoma: Real-World Data from the STAR-TOR Registry and Detailed Literature Review

Free
Subject Area:
Further Areas
Annemarie Uhlig, Lothar Bergmann, Martin Bögemann, Thomas Fischer, Peter J. Goebell, Marianne Leitsmann, Mathias Reichert, Michael Rink, Katrin Schlack, Lutz Trojan, Johannes Uhlig, Michael Woike, Arne Strauß
Journal: Urologia Internationalis
Urol Int (2024) 108 (3): 198–210.
https://doi.org/10.1159/000536563
Published Online: 02 February 2024
View article titled, Sunitinib for Metastatic Renal Cell Carcinoma: Real-World Data from the STAR-TOR Registry and Detailed Literature Review
Open the PDF for Sunitinib for Metastatic Renal Cell Carcinoma: Real-World Data from the STAR-TOR Registry and Detailed Literature Review in another window
Journal Articles

Comparison of First-Line Anti-PD-1-Based Combination Therapies in Metastatic Renal-Cell Carcinoma: Real-World Experiences from a Retrospective, Multi-Institutional Cohort

Available to Purchase
Subject Area:
Further Areas
Benedikt Hoeh, Philipp Schmucker, Niklas Klümper, Oliver Hahn, Philip Zeuschner, Severine Banek, Pierre I. Karakiewicz, Jörg Ellinger, Julia Heinzelbecker, Michael Hölzel, Arne Strauß, Friedemann Zengerling, Angelika Mattigk, Charis Kalogirou
Journal: Urologia Internationalis
Urol Int (2022) 106 (11): 1150–1157.
https://doi.org/10.1159/000521661
Published Online: 14 February 2022
View article titled, Comparison of First-Line Anti-PD-1-Based Combination Therapies in Metastatic Renal-Cell Carcinoma: Real-World Experiences from a Retrospective, Multi-Institutional Cohort
Open the PDF for Comparison of First-Line Anti-PD-1-Based Combination Therapies in Metastatic Renal-Cell Carcinoma: Real-World Experiences from a Retrospective, Multi-Institutional Cohort in another window
Journal Articles

Oncologic Response and Hospitalization Rate of Patients Receiving Cabazitaxel in the Fourth-Line and Beyond in Castration-Resistant Prostate Cancer: Analysis of a Retrospective Cohort and a Structured Literature Review

Available to Purchase
Subject Area:
Further Areas
Jost von Hardenberg, Maike Schwartz, Thorsten Werner, Stefan Fuxius, Arne Strauss, Thomas Stefan Worst, Philipp Nuhn, Christian Bolenz, Elmar Heinrich
Journal: Urologia Internationalis
Urol Int (2017) 99 (4): 414–421.
https://doi.org/10.1159/000477943
Published Online: 13 July 2017
View article titled, Oncologic Response and Hospitalization Rate of Patients Receiving Cabazitaxel in the Fourth-Line and Beyond in Castration-Resistant Prostate Cancer: Analysis of a Retrospective Cohort and a Structured Literature Review
Open the PDF for Oncologic Response and Hospitalization Rate of Patients Receiving Cabazitaxel in the Fourth-Line and Beyond in Castration-Resistant Prostate Cancer: Analysis of a Retrospective Cohort and a Structured Literature Review in another window